Edward M. MD Kaye - Dec 30, 2024 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
CEO, Director
Signature
/s/ Jonathan Allan, Attorney-in-Fact
Stock symbol
STOK
Transactions as of
Dec 30, 2024
Transactions value $
$21,000
Form type
4
Date filed
1/2/2025, 04:14 PM
Previous filing
Dec 11, 2024
Next filing
Jan 6, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STOK Common Stock Options Exercise $21K +35K +56.56% $0.60 96.9K Dec 30, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Employee Stock Option (Right to Buy) Options Exercise $0 -35K -5.81% $0.00 568K Dec 30, 2024 Common Stock 35K $0.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option became fully vested as of October 17, 2022.